Motor Data Analysis for Parkinson's (NCT06907589)
Detect subtle walking changes early
- Trial ID
- NCT06907589
- Official Title
- A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care
- Goal
- Detect subtle walking changes early
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
- Study Type
- INTERVENTIONAL
- Enrollment
- 250 participants
- Conditions
- Parkinson Disease, Healthy Adult
- Interventions
- Motor Data Analysis
Summary For Families
Aims to make Parkinson's easier to catch early and to follow over time by providing an accessible, tech-based way to measure motor signs and keep care continuous. It uses technology to record and analyze motor tasks like walking and other movements, turning those recordings into objective movement metrics that can flag subtle Parkinson's signs and show how symptoms change with medication. The trial seeks adults 50 to 80 years old, either healthy volunteers or people with Parkinson's at Hoehn and Yahr stages 1,3 who can walk without a cane and have an MMSE of 24 or higher. Parkinson's participants are examined while ON their usual medication and should not have dyskinesias or need walking aids.
Locations
- Ospedale Santa Maria Annunziata AUSL Toscana Centro, Bagno a Ripoli, Firenze, Italy
- Azienda Ospedaliero Universitaria Careggi, Florence, Italy
- IRCCS Fondazione Don Carlo Gnocchi Firenze, Florence, Italy
- Ospedale Apuane AUSL Toscana Nord Ovest, Massa, Italy
- IRCCS Istituto Auxologico Italiano, Ospedale San Luca, Milan, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Motor Data Analysis. Aims to make Parkinson's easier to catch early and to follow over time by providing an accessible, tech-based way to measure motor signs and keep care continuous. It uses technology to record and analyze motor tasks like walking and other movements, turning those recordings into objective movement metrics that can flag subtle Parkinson's signs and show how symptoms change with medication. The trial seeks adults 50 to 80 years old, either healthy volunteers or people with Parkinson's at Hoehn and Yahr stages 1,3 who can walk without a cane and have an MMSE of 24 or higher. Parkinson's participants are examined while ON their usual medication and should not have dyskinesias or need walking aids.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 5 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 8 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Wearable / at-home monitoring (non-invasive). Confirm the full schedule with the study coordinator.